New Key Statistics Module, Z-Score and F-Score
NAS:ACAD Key Ratios
Market Cap $ M | 2,612.55 |
Enterprise Value $ M | 2,169.26 |
P/E(ttm) | 87.50 |
PE Ratio without NRI | 87.50 |
Forward PE Ratio | 30.23 |
Price/Book | 5.05 |
Price/Sales | 2.90 |
Price/Free Cash Flow | 32.46 |
Price/Owner Earnings | 133.51 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 890.00 |
EPS (TTM) $ | 0.18 |
Beneish M-Score | -2.42 |
10-y EBITDA Growth Rate % | 1.10 |
5-y EBITDA Growth Rate % | 22.30 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 97.48 |
EV-to-EBITDA | 64.89 |
PEG | 3.92 |
Shares Outstanding M | 165.88 |
Net Margin (%) | 3.43 |
Operating Margin % | 2.56 |
Pre-tax Margin (%) | 5.14 |
Quick Ratio | 1.95 |
Current Ratio | 2.16 |
ROA % (ttm) | 4.03 |
ROE % (ttm) | 7.04 |
ROIC % (ttm) | 7.75 |
Dividend Yield % | -- |
Altman Z-Score | 2.03 |
ACAD Number of Guru Trades
ACAD Volume of Guru Trades
Gurus Latest Trades with NAS:ACAD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ACAD is held by these investors
Total 2
ACADIA Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:ACAD
Total 0- 1